These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8275694

  • 1. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.
    Mais V, Fruzzetti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB.
    Contraception; 1993 Nov; 48(5):445-52. PubMed ID: 8275694
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
    Paoletti AM, Orrù M, Floris S, Mannias M, Vacca AM, Ajossa S, Guerriero S, Melis GB.
    Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
    [Abstract] [Full Text] [Related]

  • 4. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
    Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Guy-Grand B, Degrelle H.
    Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
    [Abstract] [Full Text] [Related]

  • 5. Contraception in older woman.
    Volpe A, Silferi M, Genazzani AD, Genazzani AR.
    Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
    [Abstract] [Full Text] [Related]

  • 6. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 7. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [Abstract] [Full Text] [Related]

  • 8. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 11. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 12. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 13. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 14. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Worthington M, Proudler AJ, Felton C, Sidhu M, Stevenson JC.
    Contraception; 1993 Sep; 48(3):217-27. PubMed ID: 8222652
    [Abstract] [Full Text] [Related]

  • 15. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F, Ricci C, Fioretti P.
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L.
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Decreased bone turnover in oral contraceptive users.
    Garnero P, Sornay-Rendu E, Delmas PD.
    Bone; 1995 May; 16(5):499-503. PubMed ID: 7654464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.